A Single-center, Open Label Study for Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment - A Phase IIa Study
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Oshadi D (Primary) ; Oshadi R (Primary)
- Indications Mesothelioma
- Focus Adverse reactions
- 28 Mar 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018, according to ClinicalTrials.gov record.
- 28 Mar 2016 Planned initiation date changed from 1 Jul 2014 to 1 Dec 2016, according to ClinicalTrials.gov record.
- 28 Oct 2013 Planned end date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov